Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Trending Product / SARS-CoV-2

Recombinant SARS-CoV-2 NSP13 Protein, N-His

Catalog #:   YVV01801 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P0DTD1
Protein length: Ala5325-Gln5925
Overview

Catalog No.

YVV01801

Expression system

E. coli

Species

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Protein length

Ala5325-Gln5925

Predicted molecular weight

69.15 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P0DTD1

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in 50mM Tris-HCl, 0.02% NLS, pH 7.5, 5µM ZnCl2, 2mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Helicase, Hel, Non-structural protein 13, nsp13, Replicase polyprotein 1ab, pp1ab, ORF1ab polyprotein

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant SARS-CoV-2 NSP13
References

SARS-CoV-2 point mutations are over-represented in terminal loops of RNA stem-loop structures that can be resolved by Nsp13 helicase in a unique manner with respect to nucleotide dependence., PMID:40421800

Myricetin-bound crystal structure of the SARS-CoV-2 helicase NSP13 facilitates the discovery of novel natural inhibitors., PMID:40421686

Analysis of the SARS-CoV-2 inactivation mechanism using violet-blue light (405 nm)., PMID:40366184

The NSP6-L260F substitution in SARS-CoV-2 BQ.1.1 and XBB.1.16 lineages compensates for the reduced viral polymerase activity caused by mutations in NSP13 and NSP14., PMID:40358207

Structural Basis of SARS-CoV-2 Nsp13-Derived Peptide-Mediated NK Cell Activation., PMID:40331402

Structure-Activity Relationships of New 1-Aryl-1H-Indole Derivatives as SARS-CoV-2 Nsp13 Inhibitors., PMID:40322961

Chemical arsenal for helicase Hunters: Striking the toughest targets in antiviral research., PMID:40316178

Acute COVID-19 and LongCOVID syndrome - molecular implications for therapeutic strategies - review., PMID:40313948

Monitoring SARS-CoV-2 Nsp13 helicase binding activity using expanded genetic code techniques., PMID:40309067

Discovery of 4-((quinolin-8-ylthio)methyl)benzamide derivatives as a new class of SARS-CoV-2 nsp13 inhibitors., PMID:40147803

SARS-CoV-2 Nsp13 helicase modulates miR-146a-mediated signaling pathways., PMID:40073498

Duplex Unwinding Mechanism of Coronavirus MERS-CoV nsp13 Helicase., PMID:40018651

Amino acid substitutions in NSP6 and NSP13 of SARS-CoV-2 contribute to superior virus growth at low temperatures., PMID:39936915

Analogs of NIH Molecular Probe ML283 Are Potent SARS-CoV-2 Helicase Inhibitors., PMID:39910979

A novel ADP-directed chaperone function facilitates the ATP-driven motor activity of SARS-CoV helicase., PMID:39878212

SARS-CoV-2 resistance analyses from the Phase 3 PINETREE study of remdesivir treatment in nonhospitalized participants., PMID:39699245

Bat RNA viruses employ viral RHIMs orchestrating species-specific cell death programs linked to Z-RNA sensing and ZBP1-RIPK3 signaling., PMID:39697597

Mutational and evolutionary dynamics of non-structural and spike proteins from variants of concern (VOC) of SARS-CoV-2 in India., PMID:39488303

SARS-CoV-2 nsp13 suppresses hepatitis B virus replication by targeting cccDNA transcription., PMID:39373477

High throughput screening for SARS-CoV-2 helicase inhibitors., PMID:39173831

Variable Inhibition of DNA Unwinding Rates Catalyzed by the SARS-CoV-2 Helicase Nsp13 by Structurally Distinct Single DNA Lesions., PMID:39063172

A Repurposed Drug Interferes with Nucleic Acid to Inhibit the Dual Activities of Coronavirus Nsp13., PMID:38980755

Mechanistic insights into bismuth(iii) inhibition of SARS-CoV-2 helicase., PMID:38966375

Progressive Evolutionary Dynamics of Gene-Specific ω Led to the Emergence of Novel SARS-CoV-2 Strains Having Super-Infectivity and Virulence with Vaccine Neutralization., PMID:38928018

Mutation prediction in the SARS-CoV-2 genome using attention-based neural machine translation., PMID:38872567

Generalized open-source workflows for atomistic molecular dynamics simulations of viral helicases., PMID:38869150

Heterotypic immunity from prior SARS-CoV-2 infection but not COVID-19 vaccination associates with lower endemic coronavirus incidence., PMID:38865483

The Coronavirus helicase in replication., PMID:38796132

Development of a Fluorescent Assay and Imidazole-Containing Inhibitors by Targeting SARS-CoV-2 Nsp13 Helicase., PMID:38792162

Genomic Context of SARS-CoV-2 Outbreaks in Farmed Mink in Spain during Pandemic: Unveiling Host Adaptation Mechanisms., PMID:38791536

The Dual-Targeted Fusion Inhibitor Clofazimine Binds to the S2 Segment of the SARS-CoV-2 Spike Protein., PMID:38675980

Drug repurposing screen to identify inhibitors of the RNA polymerase (nsp12) and helicase (nsp13) from SARS-CoV-2 replication and transcription complex., PMID:38490582

Identification of Potential Inhibitors of the SARS-CoV-2 NSP13 Helicase via Structure-Based Ligand Design, Molecular Docking and Nonequilibrium Alchemical Simulations., PMID:38456332

The PKA-CREB1 axis regulates coronavirus proliferation by viral helicase nsp13 association., PMID:38445884

Activity and inhibition of the SARS-CoV-2 Omicron nsp13 R392C variant using RNA duplex unwinding assays., PMID:38301954

Analysis of SARS-CoV-2 genome evolutionary patterns., PMID:38197644

Role of ATP Hydrolysis and Product Release in the Translocation Mechanism of SARS-CoV-2 NSP13., PMID:38175211

Heterotypic responses against nsp12/nsp13 from prior SARS-CoV-2 infection associates with lower subsequent endemic coronavirus incidence., PMID:37961343

The Role of ATP Hydrolysis and Product Release in the Translocation Mechanism of SARS-CoV-2 NSP13., PMID:37808802

SARS-CoV-2 Nsp8 N-terminal domain folds autonomously and binds dsRNA., PMID:37665006

Diketo acid inhibitors of nsp13 of SARS-CoV-2 block viral replication., PMID:37562607

Observing inhibition of the SARS-CoV-2 helicase at single-nucleotide resolution., PMID:37560916

An iron-sulfur cluster in the zinc-binding domain of the SARS-CoV-2 helicase modulates its RNA-binding and -unwinding activities., PMID:37552760

An overview of anti-SARS-CoV-2 and anti-inflammatory potential of baicalein and its metabolite baicalin: Insights into molecular mechanisms., PMID:37437351

Identification of a 1.4-kb-Long Sequence Located in the nsp12 and nsp13 Coding Regions of SARS-CoV-2 Genomic RNA That Mediates Efficient Viral RNA Packaging., PMID:37367225

An immunoinformatics approach to study the epitopes of SARS-CoV-2 helicase, Nsp13., PMID:37362836

SARS-CoV-2 nsp13 Restricts Episomal DNA Transcription without Affecting Chromosomal DNA., PMID:37347173

SARS-CoV-2 intrahost evolution in immunocompromised patients in comparison with immunocompetent populations after treatment., PMID:37341553

A mutation in the coronavirus nsp13-helicase impairs enzymatic activity and confers partial remdesivir resistance., PMID:37338298

SARS-CoV-2 NSP13 interacts with host IRF3, blocking antiviral immune responses., PMID:37314155

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant SARS-CoV-2 NSP13 Protein, N-His [YVV01801]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only